Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Plasma ATN(I) classification and precision pharmacology in Alzheimer's disease
View through CrossRef
AbstractEvaluating potential therapies for Alzheimer's disease (AD) depends on use of biomarkers for appropriate subject selection and monitoring disease progression. Biomarkers that predict onset of clinical symptoms are particularly important for AD because they enable intervention before irreversible neurodegeneration occurs. The amyloid‐β‐tau‐neurodegeneration (ATN) classification system is currently used as a biological staging model for AD and is based on three classes of biomarkers evaluating amyloid‐β (Aβ), tau pathology and neurodegeneration or neuronal injury. Promising blood‐based biomarkers for each of these categories have been identified (Aβ42/Aβ40 ratio, phosphorylated tau, neurofilament light chain), and this matrix is now being expanded toward an ATN(I) system, where “I” represents a neuroinflammatory biomarker. The plasma ATN(I) system, together with APOE genotyping, offers a basis for individualized evaluation and a move away from the classic “one size fits all” approach toward a biomarker‐driven individualisation of therapy for patients with AD.
Title: Plasma ATN(I) classification and precision pharmacology in Alzheimer's disease
Description:
AbstractEvaluating potential therapies for Alzheimer's disease (AD) depends on use of biomarkers for appropriate subject selection and monitoring disease progression.
Biomarkers that predict onset of clinical symptoms are particularly important for AD because they enable intervention before irreversible neurodegeneration occurs.
The amyloid‐β‐tau‐neurodegeneration (ATN) classification system is currently used as a biological staging model for AD and is based on three classes of biomarkers evaluating amyloid‐β (Aβ), tau pathology and neurodegeneration or neuronal injury.
Promising blood‐based biomarkers for each of these categories have been identified (Aβ42/Aβ40 ratio, phosphorylated tau, neurofilament light chain), and this matrix is now being expanded toward an ATN(I) system, where “I” represents a neuroinflammatory biomarker.
The plasma ATN(I) system, together with APOE genotyping, offers a basis for individualized evaluation and a move away from the classic “one size fits all” approach toward a biomarker‐driven individualisation of therapy for patients with AD.
Related Results
ATN status in amnestic and non-amnestic Alzheimer’s disease and frontotemporal lobar degeneration
ATN status in amnestic and non-amnestic Alzheimer’s disease and frontotemporal lobar degeneration
AbstractUnder the ATN framework, cerebrospinal fluid analytes provide evidence of the presence or absence of Alzheimer’s disease pathological hallmarks: amyloid plaques (A), phosph...
Magnetohydrodynamics enhanced radio blackout mitigation system for spacecraft during planetary entries
Magnetohydrodynamics enhanced radio blackout mitigation system for spacecraft during planetary entries
(English) Spacecraft entering planetary atmospheres are enveloped by a plasma layer with high levels of ionization, caused by the extreme temperatures in the shock layer. The charg...
Penerapan Metode Convolutional Neural Network untuk Diagnosa Penyakit Alzheimer
Penerapan Metode Convolutional Neural Network untuk Diagnosa Penyakit Alzheimer
Abstract— Alzheimer's disease is a neurodegenerative disease that develops gradually, and is associated with cardiovascular and cerebrovascular problems. Alzheimer's is a serious d...
P539 Unmet needs in advanced therapy-naïve (ATN) and advanced therapy-experienced (ATE) moderate-to-severe (mod-sev) ulcerative colitis (UC) patients in the United States (US)
P539 Unmet needs in advanced therapy-naïve (ATN) and advanced therapy-experienced (ATE) moderate-to-severe (mod-sev) ulcerative colitis (UC) patients in the United States (US)
Abstract
Background
About a third of patients with mod-sev UC receiving advanced therapy (AT, i.e. biologics and tofacitinib) do...
A study of plasma treatments effects on dental biofilms
A study of plasma treatments effects on dental biofilms
[ACCESS RESTRICTED TO THE UNIVERSITY OF MISSOURI AT REQUEST OF AUTHOR.] Dental plaque is a biofilm that grows on surfaces within the mouth and contains millions of bacteria. The ba...
Identification of Genetic Markers and Immune Infiltration Characteristics of Alzheimer’s Disease Through Weighted Gene Co-expression Network Analysis
Identification of Genetic Markers and Immune Infiltration Characteristics of Alzheimer’s Disease Through Weighted Gene Co-expression Network Analysis
Abstract
Background: Alzheimer disease (AD) is a long-term progressive neurodegeneration disease. Studies have shown that accumulation of epigenetic changes promotes the fo...
Embedding-Assisted Attentional Deep Learning for Real-World RF Fingerprinting of Bluetooth
Embedding-Assisted Attentional Deep Learning for Real-World RF Fingerprinting of Bluetooth
<p>A computationally efficient framework to fingerprint real-world Bluetooth devices is presented in this work. Despite the active research in this topic, a generalizable fra...
Embedding-Assisted Attentional Deep Learning for Real-World RF Fingerprinting of Bluetooth
Embedding-Assisted Attentional Deep Learning for Real-World RF Fingerprinting of Bluetooth
<p>A computationally efficient framework to fingerprint real-world Bluetooth devices is presented in this work. Despite the active research in this topic, a generalizable fra...